Tuma Deepwise and Sinovation Medical Announce Strategic Partnership to Enhance Channel Collaboration and Drive Intelligent Healthcare Innovation

On October 22, VCBeat (WeChat Official Account: vcbeat) learned that Tuma Shenwei Medical Technology (Beijing) Co., Ltd. and Sinovision Technologies (Beijing) Co., Ltd. have entered into a strategic partnership. The two parties will engage in multi-dimensional collaboration focusing on product development, marketing, and channel construction. This partnership will further optimize Tuma Shenwei’s market channel layout, enhance both companies’ capabilities in technological innovation and service delivery, and jointly promote the rapid development of intelligent healthcare in China.

Group photo of Sinovision President Fu Shinong (fourth from right), Vice President Zhao Jiang (second from right), TomoDeep Founder and CEO Zhong Xin (third from right), and TomoDeep Senior Vice President Cui Jun (first from right) after signing the cooperation agreement

Zhong Xin, Founder and CEO of TumorDynamics, stated that the strategic partnership between TumorDynamics and Sinovision aims to leverage their respective resource advantages to deliver superior products and services to users, while enhancing both companies’ brand influence and channel distribution.

Fu Shinong, President of Sinovision, also stated that future collaboration between Sinovision and Tuma Shenwei will be further deepened to achieve complementary resources and mutual benefits, thereby better serving the public.

As a pioneer in intelligent healthcare, Tuma Shenwei focuses on genuine clinical needs and pain points. The company has launched multiple intelligent diagnostic systems that cover the entire workflow, including disease monitoring, quantitative analysis, disease classification, benign-malignant differentiation, follow-up tracking, and report generation. These solutions amplify medical productivity, help improve the quality of care at primary-level hospitals, and promote balanced development of healthcare standards across different regions in China.

As a leading provider of radiological imaging solutions and services, Sinovision has established an integrated industrial system for high-end medical imaging equipment, encompassing research and development, manufacturing, and sales. While maintaining its R&D advantages in high-end imaging devices centered on CT technology, the company also focuses on the extensive application and development of network functionalities and big data technologies in the healthcare sector. It provides global medical institutions with integrated solutions that combine high-end imaging equipment, cloud service platforms, and remote diagnostic technologies.

Zhong Xin has stated that emerging companies in the field of intelligent healthcare should not operate in isolation; both corporate development and product upgrades should maintain an open attitude, collaborating with upstream and downstream partners to jointly drive industry progress. This strategic partnership between two industry leaders offers new perspectives for the growth of intelligent healthcare enterprises and injects fresh momentum into the sector’s development.